Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ted Jack Kaptchuk, B.A.

Co-Author

This page shows the publications co-authored by Ted Kaptchuk and Kathryn Hall.
Connection Strength

5.493
  1. Systems pharmacogenomics - gene, disease, drug and placebo interactions: a case study in COMT. Pharmacogenomics. 2019 05; 20(7):529-551.
    View in: PubMed
    Score: 0.813
  2. Pharmacogenomics and the Placebo Response. ACS Chem Neurosci. 2018 04 18; 9(4):633-635.
    View in: PubMed
    Score: 0.750
  3. Genetics and the placebo effect: the placebome. Trends Mol Med. 2015 May; 21(5):285-94.
    View in: PubMed
    Score: 0.614
  4. Genetic biomarkers of placebo response: what could it mean for future trial design? Clin Investig (Lond). 2013 Apr 01; 3(4):311-314.
    View in: PubMed
    Score: 0.533
  5. Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome. PLoS One. 2012; 7(10):e48135.
    View in: PubMed
    Score: 0.518
  6. Genomic Effects Associated With Response to Placebo Treatment in a Randomized Trial of Irritable Bowel Syndrome. Front Pain Res (Lausanne). 2021; 2:775386.
    View in: PubMed
    Score: 0.245
  7. Assessment of Placebo Response in Objective and Subjective Outcome Measures in Rheumatoid Arthritis Clinical Trials. JAMA Netw Open. 2020 09 01; 3(9):e2013196.
    View in: PubMed
    Score: 0.223
  8. Historical Controls in Randomized Clinical Trials: Opportunities and Challenges. Clin Pharmacol Ther. 2021 02; 109(2):343-351.
    View in: PubMed
    Score: 0.223
  9. Catechol-O-Methyltransferase and Cardiovascular Disease: MESA. J Am Heart Assoc. 2019 12 17; 8(24):e014986.
    View in: PubMed
    Score: 0.212
  10. COMT and Alpha-Tocopherol Effects in Cancer Prevention: Gene-Supplement Interactions in Two Randomized Clinical Trials. J Natl Cancer Inst. 2019 07 01; 111(7):684-694.
    View in: PubMed
    Score: 0.206
  11. Correction: Catechol-O-Methyltransferase moderates effect of stress mindset on affect and cognition. PLoS One. 2019; 14(5):e0216305.
    View in: PubMed
    Score: 0.203
  12. Catechol-O-Methyltransferase moderates effect of stress mindset on affect and cognition. PLoS One. 2018; 13(4):e0195883.
    View in: PubMed
    Score: 0.189
  13. Genetic variation in catechol-O-methyltransferase modifies effects of clonidine treatment in chronic fatigue syndrome. Pharmacogenomics J. 2016 Oct; 16(5):454-60.
    View in: PubMed
    Score: 0.168
  14. Catechol-O-methyltransferase association with hemoglobin A1c. Metabolism. 2016 07; 65(7):961-967.
    View in: PubMed
    Score: 0.165
  15. Conscientiousness is modified by genetic variation in catechol-O-methyltransferase to reduce symptom complaints in IBS patients. Brain Behav. 2015 Jan; 5(1):39-44.
    View in: PubMed
    Score: 0.149
  16. Polymorphisms in catechol-O-methyltransferase modify treatment effects of aspirin on risk of cardiovascular disease. Arterioscler Thromb Vasc Biol. 2014 Sep; 34(9):2160-7.
    View in: PubMed
    Score: 0.146
  17. Dopaminergic tone does not influence pain levels during placebo interventions in patients with chronic neuropathic pain. Pain. 2018 02; 159(2):261-272.
    View in: PubMed
    Score: 0.047
  18. Network analysis of the genomic basis of the placebo effect. JCI Insight. 2017 Jun 02; 2(11).
    View in: PubMed
    Score: 0.045
  19. Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial. Trials. 2017 05 25; 18(1):234.
    View in: PubMed
    Score: 0.044
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.